缓和紧张状况 发表于 2025-3-21 18:01:21

书目名称Development and Manufacture of Protein Pharmaceuticals影响因子(影响力)<br>        http://figure.impactfactor.cn/if/?ISSN=BK0269917<br><br>        <br><br>书目名称Development and Manufacture of Protein Pharmaceuticals影响因子(影响力)学科排名<br>        http://figure.impactfactor.cn/ifr/?ISSN=BK0269917<br><br>        <br><br>书目名称Development and Manufacture of Protein Pharmaceuticals网络公开度<br>        http://figure.impactfactor.cn/at/?ISSN=BK0269917<br><br>        <br><br>书目名称Development and Manufacture of Protein Pharmaceuticals网络公开度学科排名<br>        http://figure.impactfactor.cn/atr/?ISSN=BK0269917<br><br>        <br><br>书目名称Development and Manufacture of Protein Pharmaceuticals被引频次<br>        http://figure.impactfactor.cn/tc/?ISSN=BK0269917<br><br>        <br><br>书目名称Development and Manufacture of Protein Pharmaceuticals被引频次学科排名<br>        http://figure.impactfactor.cn/tcr/?ISSN=BK0269917<br><br>        <br><br>书目名称Development and Manufacture of Protein Pharmaceuticals年度引用<br>        http://figure.impactfactor.cn/ii/?ISSN=BK0269917<br><br>        <br><br>书目名称Development and Manufacture of Protein Pharmaceuticals年度引用学科排名<br>        http://figure.impactfactor.cn/iir/?ISSN=BK0269917<br><br>        <br><br>书目名称Development and Manufacture of Protein Pharmaceuticals读者反馈<br>        http://figure.impactfactor.cn/5y/?ISSN=BK0269917<br><br>        <br><br>书目名称Development and Manufacture of Protein Pharmaceuticals读者反馈学科排名<br>        http://figure.impactfactor.cn/5yr/?ISSN=BK0269917<br><br>        <br><br>

外星人 发表于 2025-3-21 20:47:02

1078-0467 aging system, the manufacturing process, and appropriate control strategies to assure such good manufacturing practice attributes as safety, identity, strength,978-1-4613-5127-6978-1-4615-0549-5Series ISSN 1078-0467

gonioscopy 发表于 2025-3-22 02:35:59

Development and Manufacture of Protein Pharmaceuticals

Fsh238 发表于 2025-3-22 08:09:32

https://doi.org/10.1007/978-3-642-61275-6ture does not yet permit the more straightforward type of analysis utilized for small molecules to be simply applied. Nevertheless, it is still possible to treat proteins primarily as chemical (rather than biological) entities through an understanding of their structure and stability and use of a mo

collateral 发表于 2025-3-22 11:49:55

http://reply.papertrans.cn/27/2700/269917/269917_5.png

向外 发表于 2025-3-22 13:04:05

Preformulation Studies as an Essential Guide to Formulation Development and Manufacture of Protein aceutically acceptable drug substance. In the case of conventional, small-molecule (nonmacromolecular) pharmaceuticals, this procedure can usually be accomplished to a high degree of scientific rigor. For example, the atomic level structures of these compounds are usually known from a combination of

向外 发表于 2025-3-22 19:21:58

http://reply.papertrans.cn/27/2700/269917/269917_7.png

Aesthete 发表于 2025-3-22 21:16:25

Aseptic Processing of Protein Pharmaceuticals,h clinical supplies and the commercial market, from the perspective of the unique characteristics of protein-containing drug products. The discussion will be restricted to solution, suspension, and lyophilized dosage forms in final containers made of glass or plastic. It will present a conceptual fr

entreat 发表于 2025-3-23 04:45:17

http://reply.papertrans.cn/27/2700/269917/269917_9.png

maudtin 发表于 2025-3-23 08:43:44

http://reply.papertrans.cn/27/2700/269917/269917_10.png
页: [1] 2 3 4 5
查看完整版本: Titlebook: Development and Manufacture of Protein Pharmaceuticals; Steve L. Nail,Michael J. Akers Book 2002 Springer Science+Business Media New York